Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT)

This study has been completed.
Information provided by (Responsible Party):
BIAL Industrial Farmacéutica S.A. Identifier:
First received: December 2, 2011
Last updated: December 7, 2011
Last verified: December 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)